TrialInvestigative and clinical urology2016

The PREVAIL trial of enzalutamide in men with chemotherapy-naïve, metastatic castration-resistant prostate cancer: Post hoc analysis of Korean patients.

Choung-Soo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.